Proal A, Marshall T
Many people who have used a GLP-1 medication already know how to give subcutaneous (SubQ) injections
If the research context also involves chronic inflammation, gut-related models, or autoimmune-style settings, KPV is what KLOW adds
Topical makes the most sense for: Facial skin texture, fine lines, hydration Scalp application for localized hair growth Scar treatment or post-procedure recovery on a specific area Patients who want to fold GHK-Cu into an existing skincare routine Injectable makes the most sense for: Systemic wound healing (especially internal or in areas you can't easily apply cream) Joint and connective tissue support (topical simply can't penetrate deep enough) Broader anti-aging goals beyond the skin surface Patients already running other injectable peptide protocols (CJC-1295/ipamorelin, BPC-157, TB-500) Here's the thing: for joints specifically, there's no argument
Researchers continue to investigate its influence on dermal papilla cell signaling, extracellular matrix regulation, angiogenic signaling, and the biological pathways that support normal hair follicle function and skin physiology